- Home
- KALA vs VSTD Comparison
KALA vs VSTD Comparison
Compare KALA & VSTD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALA
- VSTD
- Stock Information
- Founded
- KALA 2009
- VSTD 2016
- Country
- KALA United States
- VSTD United States
- Employees
- KALA N/A
- VSTD N/A
- Industry
- KALA Biotechnology: Pharmaceutical Preparations
- VSTD Restaurants
- Sector
- KALA Health Care
- VSTD Consumer Discretionary
- Exchange
- KALA Nasdaq
- VSTD Nasdaq
- Market Cap
- KALA 26.2M
- VSTD 25.9M
- IPO Year
- KALA 2017
- VSTD 2022
- Fundamental
- Price
- KALA $1.67
- VSTD $1.36
- Analyst Decision
- KALA Buy
- VSTD
- Analyst Count
- KALA 3
- VSTD 0
- Target Price
- KALA $31.50
- VSTD N/A
- AVG Volume (30 Days)
- KALA 2.7M
- VSTD 4.5M
- Earning Date
- KALA 11-11-2025
- VSTD 11-18-2025
- Dividend Yield
- KALA N/A
- VSTD N/A
- EPS Growth
- KALA N/A
- VSTD N/A
- EPS
- KALA N/A
- VSTD N/A
- Revenue
- KALA N/A
- VSTD $13,902,861.00
- Revenue This Year
- KALA N/A
- VSTD N/A
- Revenue Next Year
- KALA N/A
- VSTD N/A
- P/E Ratio
- KALA N/A
- VSTD N/A
- Revenue Growth
- KALA N/A
- VSTD 30.39
- 52 Week Low
- KALA $1.10
- VSTD $0.68
- 52 Week High
- KALA $20.60
- VSTD $5.63
- Technical
- Relative Strength Index (RSI)
- KALA 27.87
- VSTD N/A
- Support Level
- KALA $1.26
- VSTD N/A
- Resistance Level
- KALA $1.69
- VSTD N/A
- Average True Range (ATR)
- KALA 1.14
- VSTD 0.00
- MACD
- KALA -1.93
- VSTD 0.00
- Stochastic Oscillator
- KALA 2.80
- VSTD 0.00
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
About VSTD Vestand Inc. Class A Common Stock
Vestand Inc is a restaurant operator. The company has one reportable segment, consisting of operating its stores. It serves the perfect, ideal ramen, as well as offers customers a wide variety of sushi, bento menus, and other favorite Japanese cuisines. It owns and operates restaurant stores.